Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer's disease-finding from Alzheimer's Disease Neuroimaging Initiative. Here, EPHX2 is linked to early-onset autosomal dominant Alzheimer disease.